Image source: Upsplash/The Motley Fool
CDs are currently paying pretty high yields. In fact, ther...
Realty Income (NYSE: O) shares have struggled over the past year -- they're down over 10%. However, ...
One of the most surprising bits of news from this year's Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK...
According to billionaire investor Warren Buffett, achieving excellent returns as an investor is main...
What's happened to the artificial intelligence (AI) rally?
It's the question many investors are as...
Image source: The Motley Fool/Unsplash
Most airlines with rewards or miles programs also have eli...
Bitcoin (CRYPTO: BTC) is gaining widespread acceptance as an asset that will be around for a while, ...
Many famous names on Wall Street are rapidly scooping up shares of the most prominent artificial int...
Many healthcare investors look at Johnson & Johnson (NYSE: JNJ) and see a good, safe dividend st...
The S&P 500 is arguably the most followed stock index in the world. It's existed in its current ...
When looking at some of the best performing stocks of the past decade, there's no question that Tesl...
Fool.com contributor Parkev Tatevosian discusses what the latest development could mean for Luminar ...
With shares up by an eye-watering 129% year to date, SoundHound AI (NASDAQ: SOUN) is one of 2024's h...
Image source: The Motley Fool/Upsplash
Getting that first $1,000 in investable savings is a good ...
Meta Platforms (NASDAQ: META) has made for a terrific investment since its initial public offering i...
Finding the right stocks for your portfolio doesn't have to be difficult. Great businesses are built...
If you are looking for an exchange-traded fund (ETF) that will provide you with dividend income, you...
Warren Buffett hasn't found a lot to like in the stock market recently.
In each of the last six qua...
Image source: Getty Images
Early in the pandemic, it was clear that the world was about to change...
Social Security is the cornerstone of many Americans' retirement plans. 59% of retirees say their mo...
It's a race to the riches in the anti-obesity drug market. This therapeutic area is projected to gro...